Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Animal Drugs Market
Animal Drugs Market size crossed USD 35 billion in 2022 and is projected to expand at a 5.4% CAGR from 2023-2032.
Increasing cases of obesity in companion animals will affect animal drugs industry dynamics. Obesity is a major healthcare concern among pet parents and in animal husbandry as it induces a higher risk of osteoarthritis & diabetes mellitus, reduces the quality of life, and shortens life span.
Due to increasing incidences of animal obesity, the demand for animal drugs is anticipated to pick up pace in the near future. As per the Veterinary Centers of America (VCA) data, approximately 25% to 30% of the general dog population in the U.S. is obese, with 40%-45% of dogs within 5-11 years of age weighing more than the ideal body mass index (BMI).
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Animal Drugs Market Size in 2022: | USD 35 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 5.4% |
2032 Value Projection: | USD 59.5 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 344 |
Tables, Charts & Figures: | 588 |
Segments covered: | Product, Animal Type, Route of Administration, Distribution Channel and Region. |
Growth Drivers: |
|
Pitfalls & Challenges: |
|